Dihydroartemisinin attenuates ischemia/reperfusion-induced renal tubular senescence by activating autophagy

Chin J Nat Med. 2023 Sep;21(9):682-693. doi: 10.1016/S1875-5364(23)60398-X.


Acute kidney injury (AKI) is an important factor for the occurrence and development of CKD. The protective effect of dihydroartemisinin on AKI and and reported mechanism have not been reported. In this study, we used two animal models including ischemia-reperfusion and UUO, as well as a high-glucose-stimulated HK-2 cell model, to evaluate the protective effect of dihydroartemisinin on premature senescence of renal tubular epithelial cells in vitro and in vivo. We demonstrated that dihydroartemisinin improved renal aging and renal injury by activating autophagy. In addition, we found that co-treatment with chloroquine, an autophagy inhibitor, abolished the anti-renal aging effect of dihydroartemisinin in vitro. These findings suggested that activation of autophagy/elimination of senescent cell might be a useful strategy to prevent AKI/UUO induced renal tubular senescence and fibrosis.

Keywords: AKI; Autophagy; Dihydroartemisinin; Fibrosis; Renal tubular senescence.

MeSH terms

  • Acute Kidney Injury* / chemically induced
  • Acute Kidney Injury* / drug therapy
  • Animals
  • Autophagy
  • Ischemia
  • Kidney
  • Reperfusion
  • Reperfusion Injury* / drug therapy


  • artenimol